Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Short term Debt (2014 - 2026)

Skinvisible's (SKVI) quarterly Short term Debt came in at $128445.0 in Q2 2026, up 877.21% year-over-year from $13144.0 in Q2 2025, and up 108.7% quarter-over-quarter from $61544.0 in Q1 2026.

Analysis

Skinvisible (SKVI) Short term Debt (2014 - 2026) Analysis & Trends

Skinvisible has disclosed Short term Debt across 12 years of filings, most recently posting $128445.0 for Q2 2026.

  • In Q2 2026, Short term Debt rose 877.21% year-over-year to $128445.0; the TTM figure through Jun 2026 stood at $128445.0 (up 877.21% YoY), while the FY2025 annual figure was $45044.0, up 237.05% from the prior year.
  • Short term Debt came in at $128445.0 for Q2 2026 at Skinvisible, up from $61544.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $128445.0 in Q2 2026 to a low of $2000.0 in Q3 2023.
  • Average Short term Debt over 4 years is $27457.8, with a median of $11294.0 recorded in 2025.
  • Year-over-year, Short term Debt surged 122.73% in 2024 and jumped 877.21% in 2026.
  • Over 4 years, Short term Debt stood at $6000.0 in 2023, then soared by 122.73% to $13364.0 in 2024, then jumped by 237.05% to $45044.0 in 2025, then soared by 185.15% to $128445.0 in 2026.
  • Per Business Quant data, the three most recent Short term Debt figures were $128445.0 in Q2 2026, $61544.0 in Q1 2026, and $45044.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.03 Bn 625.27 Bn 17.26 Bn
2 AbbVie 441.56 Bn 434.99 Bn 12.70 Bn
3 Merck 364.45 Bn 357.31 Bn 12.21 Bn
4 Novartis Ag 267.46 Bn 259.77 Bn 11.24 Bn
5 Pfizer 158.77 Bn 147.08 Bn 10.94 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn
7 Revolution Medicines 44.15 Bn 44.15 Bn -
8 Incyte 25.31 Bn 20.77 Bn 1.57 Bn
9 United Therapeutics 21.29 Bn 18.63 Bn 683.80 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 128,445.00
Mar 31, 2026 61,544.00
Dec 31, 2025 45,044.00
Sep 30, 2025 33,944.00
Jun 30, 2025 13,144.00
Mar 31, 2025 9,444.00
Dec 31, 2024 13,364.00
Sep 30, 2024 9,364.00
Jun 30, 2024 4,200.00
Mar 31, 2024 3,000.00
Dec 31, 2023 6,000.00
Sep 30, 2023 2,000.00
Mar 31, 2021 500.00
Dec 31, 2020 7,616.00
Sep 30, 2020 12,807.00
Jun 30, 2020 11,818.00
Mar 31, 2020 9,274.00
Dec 31, 2019 9,274.00
Sep 30, 2019 3,565.00
Jun 30, 2019 3,565.00